Prolactin response to d-fenfluramine in combat-related post-traumatic stress disorder

International Journal of Neuropsychopharmacology

Volumn 7, Issue 3, 2004, Pages 291-298

  Schweitzer, Isaac ^a   Morris, Philip ^b   Hopwood, Malcolm ^a   Maguire, Kay ^a   Norman, Trevor ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Combat related post traumatic stress disorder; d fenfluramine; Depression; Prolactin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; DEXFENFLURAMINE; PROLACTIN; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; SEROTONINERGIC SYSTEM;

ADULT; ALCOHOLISM; AREA UNDER CURVE; COMBAT DISORDERS; FEMALE; FENFLURAMINE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; TOBACCO USE DISORDER; VETERANS;

EID: 4444354818     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004195     Document Type: Article

References (32)

1. APA (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised). Washington, DC: American Psychiatric Association.
2. Arora RC, Fichtner CG, O'Connor F, Crayton JW (1993). Paroxetine binding in the blood platelets of post-traumatic stress disorder patients. Life Sciences 53, 919-928.
3. Cicin-Sain L, Mimica N, Hranilovic D, Balija M, Ljubin T, Makaric G, Folnegovic-Smalc V, Jernej B (2000). Posttraumatic stress disorder and platelet serotonin measures. Journal of Psychiatric Research 34, 155-161.
4. Cleare AJ, Murray RM, O'Keane V (1996). Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology 14, 349-354.
5. Davidson J, Pearlstein T, Londborg P, Brady KY, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G (2001). Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. American JournaI of Psychiatry 158, 1974-1981.
6. Davidson J, Smith R, Kudler H (1989). Validity and reliability of the DSM-III criteria for post-traumatic stress disorder-experience with a structured interview. Journal of Nervous and Mental Disease 177, 336-346.
7. Davis LL, Clark M, Kramer GL, Moeller FG, Petty F (1999). D-Fenfluramine challenge in posttraumatic stress disorder. Biological Psychiatry 45, 928-930.
8. Dinan TG, Barry S, Yatham YN, Mobayed M, Brown I (1990). A pilot study of a neuroendocrine test battery in posttraumatic stress disorder. Biological Psychiatry 28, 665-672.
9. Folstein MF, Folstein SE, McHugh PR (1975). 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
10. Grossman R, Yehuda R, Boisoneau D, Schmeidler J, Giller EL (1996). Prolactin response to low-dose dexamethasone challenge in combat-exposed veterans with and without posttraumatic stress disorder and normal controls. Biological Psychiatry 40, 1100-1105.
11. Hamilton M (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 50.
12. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
13. Horowitz M, Wilner N, Alvarez W (1979). Impact of events scale: a measure of subjective distress. Psychosomatic Medicine 41, 209-218.
14. Kavoussi RJ, Kramer J, Hauger RL, Coccaro EF (1998). Prolactin response to d-fenfluramine in outpatients with major depression. Psychiatry Research 79, 199-205.
15. Keane TM, Fairbank JA, Caddell JM, Zimmering RT, Taylor KL, Mora CA (1989). Clinical evaluation of a measure to assess combat exposure. Psychological Assessment 1, 53-55.
16. Lesch KP, Wolozin BL, Murphy DL, Riederer P (1993). Primary structure of the human platelet serotonin uptake site. Identity with the brain serotonin transporter. Journal of Neurochemistry 60, 2319-2322.
17. Maes M, Lin A, Verkerk R, Delmeire L, Gastel AV, Van der Planken M, Scharpe S (1999). Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression. Neuropsychopharmacology 20, 188-197.
18. Maguire K, Norman T, Burrows G, Hopwood M, Morris P (1998). Platelet paroxetine binding in post-traumatic stress disorder. Psychiatry Research 77, 1-7.
19. Marshall RD, Beebe KL, Oldham M, Zaninelli R (2001). Efficacy and safety of paroxetine for chronic PTSD: a fixed-dose, placebo-controlled study. American Journal of Psychiatry 158, 1982-1988.
20. Martenyi F, Brown EB, Zhang H, Koke SC, Prakash A (2002a). Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. British Journal of Psychiatry 181, 315-320.
21. Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC (2002b). Fluoxetine versus placebo in posttraumatic stress disorder. Journal of Clinical Psychiatry 63, 199-206.
22. McBride PA, Tierney H, De Meo M, Chen JS, Mann JJ (1990). Effects of age and gender on CNS serotonergic responsivity in normal adults. Biological Psychiatry 27, 1143-1155.
23. Mellman TA, Kumar AM (1994). Platelet serotonin measures in posttraumatic stress disorder. Psychiatry Research 53, 99-101.
24. Muck-Seler D, Pivac N, Jakovljevic M, Sagud M, Mihaljevic-Peles A (2003). Platelet 5-HT concentration and comorbid depression in war veterans with and without posttraumatic stress disorder. Journal of Affective Disorders 75, 171-179.
25. O'Keane V, Dinan TG (1991). Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. American Journal of Psychiatry 148, 1009-1015.
26. Park SBG, Williamson DJ, Cowen PJ (1996). 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to d-fenfluramine. Psychological Medicine 26, 1191-1196.
27. Pivac N, Muck-Seler D, Sagud M, Jakovljevic M (2002). Platelet serotonergic markers in posttraumatic stress disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26, 1193-1198.
28. Quattrone A, Tedeschi G, Aguglia U, Scopacasa F, Direnzo GF, Annunziato L (1983). Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. British Journal of Clinical Pharmacology 16, 471-475.
29. Southwick SM, Krystal JH, Bremner JD, Morgan CA, Nicolaou A, Nagy LM, Johnson DR, Heninger GR, Charney DS (1997). Noradrenergic and serotonergic function in posttraumatic stress disorder. Archives of General Psychiatry 54, 749-758.
30. Spivak B, Vered Y, Graff E, Blum I, Mester R, Weizman A (1999). Low platelet-poor plasma concentrations of serotonin in patients with combat-related post-traumatic stress disorder. Biological Psychiatry 45, 840-845.
31. Weizman R, Laor N, Schujovitsky A, Wolmer L, Abramovitz-Schnaider P, Freudstein-Dan A, Rehavi M (1996). Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment. Psychiatry Research 63, 143-150.
32. WHO (1987). Composite International Diagnostic Interview. Geneva: World Health Organisation.